期刊文献+

NS-398对人肝癌BEL-7402细胞凋亡作用及其机制的研究

NS-398 Regulation on Apoptosis in Hepatocullar Carcinoma BEL-7402 Cell Lines
下载PDF
导出
摘要 目的:本研究应用NS-398对肝癌细胞株进行药物干预,探讨NS-398对肝细胞癌凋亡的影响。方法:NS-398取0、25、50、75、100μmol/L5个浓度组,每个浓度组选取24h、48h、72h三个作用时间点。MTT法测定生长抑制情况,FCM检测细胞周期、凋亡率和Survivin、cyclinD1、PTEN的表达。结果:NS-398可以显著抑制BEL-7402细胞增殖,使G0/G1期比例显著降低;G2/M期比例显著增高并且诱导细胞凋亡(P<0.001),并呈时间和剂量依赖性。与对照组相比,NS-398使Survivin、cyclinD1、PTEN蛋白表达显著下调并呈时间和剂量依赖性关系(P<0.001)。结论:NS-398可诱导BEL-7402细胞凋亡,可能部分通过下调Survivin和PTEN途径实现的。 Objective: To apply NS-398 for medicinal intervention of the cell lines of liver cancer and to investigate the influence of NS-398 on apoptosis of hepatocellular carcinoma. Methods: The media containing various concentrations of NS-398 (0, 25, 50, 75 and 100μmol/L) were used for concentration-dependent experiments. Three time-points (24h, 48h, 72h) of action time were taken for each concentration group, and the cells were collected daily for 3 days. The inhibition effect of cell growth was measured using MTT assay. Changes of cell eyc, le, the apoptotic cells and expression of survivin, cyclin D1 and PTEN after treatment with NS-398 were detected by flow cytometry method. Results: Treatment of with NS-398 significantly suppressed cell proliferation in time- and dose-dependent manner both. The percentage of cells in G0/G1 phase decreased as the percentage of cells in G2/M phase significantly increased in cultures treated with NS-398. NS-398 also induced the apoptosis detected by flow cytometry method. We found that NS-398 treatment significantly downregulated the expression of survivin, cyclin D1 and PTEN in a dose-dependence and time-dependent manner (P〈0.001). Conclusion: This study suggests that NS-398 can inhibited the proliferation and induced apoptosis of hepatoma cell, which may be partially fulfilled by downregulation of the survivin and PTEN.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第8期452-454,457,共4页 Chinese Journal of Clinical Oncology
基金 河北省卫生厅医学科研基金项目资助(课题号:04027)
关键词 肝细胞癌 NS-398 凋亡PTEN SURVIVIN Hepatocellular carcinoma NS-398 PTEN Survivin Apoptosis
  • 相关文献

参考文献10

  • 1Koga H,Sakisaka S,Ohishi M,et al.Expression of cyclooxygenase-2 in human hepatocellular carcinoma:relevance to tumor dedifferentiation[J].Hepatology,1999,29(3):688~696
  • 2Hu KQ,Yu CH,Mineyama Y,et al.Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398,a selective COX-2 inhibitor[J].IntJ Oncol,2003,22(4):757~763
  • 3Smith ML,Hawcroft G,Hull MA.The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells:evidence of different mechanisms of action[J].Eur J Cancer,2000,36(5):664~674
  • 4Tegeder I,Pfeilschifter J,Geisslinger G.Cyclooxygenase-independent actions of cyclooxygenase inhibitors[J].FASEB J,2001,15(12):2057~2072
  • 5Catalano A,Graciotti L,Rinaldi L,et al.Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention[J].IntJ Cancer,2004,109(3):322 ~328
  • 6Li F,Ambrosini G,Chu EY,et al.Control of apoptosis and mitotic spindle checkpoint by Survivin[J].Nature,1998,396(6711):580~584
  • 7彭利,左连富,齐凤英,王顺祥,张凤瑞,郭建文,刘江惠.凋亡抑制基因Survivin在肝癌细胞中的表达及其与PTEN、cyclin D1蛋白表达的关系[J].中国肿瘤临床,2005,32(1):29-33. 被引量:9
  • 8Pennisi E.New tumor suppressor found-twice[J].Science,1997,275(5308):1876~1878
  • 9Yao YJ,Ping XL,Zhang H,et al.PTEN/MMAC1 mutation in hepatocullar carcinomas[J].Oncogene,1999,18(20):3181~3185
  • 10Kawamura N,Nagai H,Bando K,et al.PTEN/MMAC1 mutation in hepatocullar carcinomas:somatic inactivation of both alleles tumors[J].Jpn J Cancer Res,1999,90(4):413~418

二级参考文献10

  • 1Lu GD, Altiefi DG, Tanigawa N. Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apotosis and p53 accumulation in gastric carcinomas [J]. Cancer Res, 1998, 58(9): 1808-1812.
  • 2Lauffenburger DA, Horwitz AF. Cell migration: A physically in-tegrated molecular process[J]. Cell, 1996, 84(3): 359-369.
  • 3Li F,Ambrosini G,Chu EY,et a1.Control of apoptosis and mi-totic spindle checkpoint by survivin [J]. Nature, 1998, 396(6711):580-584.
  • 4Suzuki A, Ito T, Kawano H, et al, Survivin initiates procaspas3/p21 complex formation as a result of interaction with CDK4 to resist Fas-mcdiated cell death[J]. Oncogene, 2000, 19(10): 13461353.
  • 5Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain,breast and prostate cancer[J]. Science, 1997, 275 (5308): 1943-1947.
  • 6Pennisi E. New tumor suppressor found-twice [J]. Science, 1997,275(5308): 1876-1878.
  • 7Piao Z, Park G, Park JH, et al, Allelotype analysis of hepatocellu-lar carcinoma[J], lnt J Cancer, 1998, 75(1): 29-33.
  • 8Carter BZ, Milella M, Altieri DC, et al. Cytokine-regulated ex-pression of survivin in myeloid leukemia [J]. Blood, 2001, 97 (9):2784-2790.
  • 9Suzuki A, Hayashida M, Ito T, et al, Survivln initiates cell cycle entry by the competitive interaction with CDK4/p16 (INK4a) and Cdk2/CydinE complex activation [J]. Oncogene, 2000, 19 (29):3225 -3234.
  • 10游建,陈孝平,张万广.凋亡抑制蛋白Survivin在肝癌中的表达及其与临床特征的关系[J].中华实验外科杂志,2003,20(9):858-858. 被引量:6

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部